Role of TP53 Mutations in the Origin and Evolution of Therapy-Related Acute Myeloid Leukemia

被引：0
|
作者：
Wong, T. N. [1 ]
Ramsingh, G. [2 ]
Young, A. L. [3 ]
Miller, C. A. [4 ]
Touma, W. [1 ]
Welch, J. S. [1 ]
Lamprecht, T. L. [1 ]
Shen, D. [6 ]
Hundal, J. [4 ]
Fulton, R. S. [4 ]
Heath, S. [1 ]
Baty, J. D. [7 ]
Klco, J. M. [8 ]
Ding, L. [1 ,5 ]
Mardis, E. R. [4 ,5 ,9 ]
Westervelt, P. [1 ,5 ]
DiPersio, J. F. [1 ,5 ]
Walter, M. J. [1 ,5 ]
Graubert, T. A. [1 ,5 ]
Ley, T. J. [1 ,5 ]
Druley, T. E. [3 ]
Link, D. C. [1 ,5 ]
Wilson, R. K. [4 ,5 ,9 ]
机构：
[1] Washington Univ, Dept Med, Div Oncol, St Louis, MO 63130 USA
[2] Univ So Calif, Dept Med, Div Hematol, Los Angeles, CA USA
[3] Washington Univ, Dept Pediat, Div Hematol Oncol, St Louis, MO 63130 USA
[4] Washington Univ, Genome Inst, St Louis, MO 63130 USA
[5] Washington Univ, Siteman Canc Ctr, St Louis, MO 63130 USA
[6] AstraZeneca, Gaithersburg, MD USA
[7] Washington Univ, Div Biostat, St Louis, MO 63130 USA
[8] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA
[9] Washington Univ, Dept Genet, St Louis, MO 63130 USA
来源：
ANNALS OF HEMATOLOGY | 2015年 / 94卷
关键词：
DETECTABLE CLONAL MOSAICISM; INACTIVATION PATTERNS; AGE; CANCER; HEMATOPOIESIS; GENOME; CELLS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S60 / S62
页数：3
相关论文
共 50 条
  • [1] Role of TP53 Mutations in the Origin and Evolution of Therapy-Related Acute Myeloid Leukemia
    Wong, T. N.
    Ramsingh, G.
    Young, A. L.
    Miller, C. A.
    Touma, W.
    Welch, J. S.
    Lamprecht, T. L.
    Shen, D.
    Hundal, J.
    Fulton, R. S.
    Heath, S.
    Baty, J. D.
    Klco, J. M.
    Ding, L.
    Mardis, E. R.
    Westervelt, P.
    DiPersio, J. F.
    Walter, M. J.
    Graubert, T. A.
    Ley, T. J.
    Druley, T. E.
    Link, D. C.
    Wilson, R. K.
    ANNALS OF HEMATOLOGY, 2015, 94 (SUPPL 1) : 60 - 62
  • [2] Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
    Wong, Terrence N.
    Ramsingh, Giridharan
    Young, Andrew L.
    Miller, Christopher A.
    Touma, Waseem
    Welch, John S.
    Lamprecht, Tamara L.
    Shen, Dong
    Hundal, Jasreet
    Fulton, Robert S.
    Heath, Sharon
    Baty, Jack D.
    Klco, Jeffery M.
    Ding, Li
    Mardis, Elaine R.
    Westervelt, Peter
    DiPersio, John F.
    Walter, Matthew J.
    Graubert, Timothy A.
    Ley, Timothy J.
    Druley, Todd E.
    Link, Daniel C.
    Wilson, Richard K.
    NATURE, 2015, 518 (7540) : 552 - 555
  • [3] Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
    Terrence N. Wong
    Giridharan Ramsingh
    Andrew L. Young
    Christopher A. Miller
    Waseem Touma
    John S. Welch
    Tamara L. Lamprecht
    Dong Shen
    Jasreet Hundal
    Robert S. Fulton
    Sharon Heath
    Jack D. Baty
    Jeffery M. Klco
    Li Ding
    Elaine R. Mardis
    Peter Westervelt
    John F. DiPersio
    Matthew J. Walter
    Timothy A. Graubert
    Timothy J. Ley
    Todd E. Druley
    Daniel C. Link
    Richard K. Wilson
    Nature, 2015, 518 : 552 - 555
  • [4] Preexisting TP53 mutation in therapy-related acute myeloid leukemia
    Schulz, Eduard
    Kashofer, Karl
    Heitzer, Ellen
    Mhatre, Ketaki N.
    Speicher, Michael R.
    Hoefler, Gerald
    Sill, Heinz
    ANNALS OF HEMATOLOGY, 2015, 94 (03) : 527 - 529
  • [5] Preexisting TP53 mutation in therapy-related acute myeloid leukemia
    Eduard Schulz
    Karl Kashofer
    Ellen Heitzer
    Ketaki N. Mhatre
    Michael R. Speicher
    Gerald Hoefler
    Heinz Sill
    Annals of Hematology, 2015, 94 : 527 - 529
  • [6] The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML
    Wong, Terrence Neal
    Ramsingh, Giridharan
    Young, Andrew
    Shen, Dong
    Miller, Chris
    Lamprecht, Tamara
    Heath, Sharon
    Fulton, Robert S.
    Mardis, Elaine R.
    Ding, Li
    Westervelt, Peter
    Welch, John
    Walter, Matthew J.
    Graubert, Timothy
    DiPersio, John F.
    Ley, Timothy J.
    Druley, Todd E.
    Wilson, Richard K.
    Link, Daniel C.
    BLOOD, 2013, 122 (21)
  • [7] TP53 and therapy-related myeloid neoplasms
    Chung, Jae
    Sallman, David A.
    Padron, Eric
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (01) : 98 - 103
  • [8] TP53 germline mutations occur in acute myeloid leukemia and are associated with therapy-related cases following ionizing radiation
    Zebisch, A.
    Lal, R.
    Mueller, M.
    Lind, K.
    Sill, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S385 - S386
  • [9] TP53 mutations in therapy -related acute myeloid leukemia: still the dark side of the moon?
    Molica, Matteo
    Rossi, Marco
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023, 133 (01):
  • [10] SELECTION OF A PRE-EXISTING TP53 MUTATED CLONE IN THERAPY-RELATED ACUTE MYELOID LEUKEMIA
    Schulz, E.
    Kashofer, K.
    Mhatre, K. N.
    Hoefler, G.
    Sill, H.
    HAEMATOLOGICA, 2014, 99 : 15 - 15
12345